Ayala Pharmaceuticals, Inc.

ADXSOTCHealthcare

$0.60

+$0.00(+0.00%)

Market Cap$25707577

P/E Ratio—

52W High$0.801

52W Low$0.0011

Avg Volume5K

Open$0.10

Beta-4.03

Net Income Financials Revenue

Ayala Pharmaceuticals, Inc. (ADXS) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

ADXS · net income · updated Jun 15, 2026

Core profitability metrics

ADXS · net income · margin · TTM · CAGR

Net income was −$48.1M for FY2023 (fiscal year ending 2023-12-31), down 234.8% year-over-year. Net profit margin was -369784.6%. Based on available data, Ayala Pharmaceuticals, Inc. has been profitable since at least 2009.

FY2023 Net Income−$48.1M▼ -234.8% YoY

Trailing 12M (TTM)−$48.1Mtrailing 4 quarters sum

Net Profit Margin< −999%−$48.1M ÷ $13,000

YoY Change-234.8%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 15, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2009

▸ FMP /income-statement · Annual · ADXS net income history · ADXS profit margin

Annual net income data

ADXS · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2023Loss−$48.1M▼ 234.8%-369784.6%$13,000

FY2022Loss−$14.4M▲ +19.6%-5743.6%$250,000

FY2021Loss−$17.9M▲ +32.5%-551.3%$3.2M

FY2020Loss−$26.5M▼ 48.8%-10462.1%$253,000

FY2019Loss−$17.8M▲ +73.3%-762.3%$2.3M

Net income vs peers (Healthcare)

ADXS vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Ayala Pharmaceuticals, Inc.YOU

ADXS

−$48.1M-234.8%-369784.6%

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Ayala Pharmaceuticals, Inc. (ADXS) reported net income of −$48.1M for FY2023 (fiscal year ending 2023-12-31), down 234.8% year-over-year. The net profit margin was -369784.6% — meaning the company kept $-3697.85 of every dollar of revenue as profit.

Based on available data, Ayala Pharmaceuticals, Inc. has been profitable since at least 2009. Net income reached a peak of $929,244 in FY2009. Data available for 15 fiscal years.

Ayala Pharmaceuticals, Inc.'s net profit margin was -369784.6% for FY2023, based on the latest annual results.

Investors sometimes search for "Ayala Pharmaceuticals, Inc. net worth" — the company's market capitalization is a separate figure from ADXS net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

ADXS net income · 4 questions

Ayala Pharmaceuticals, Inc. is not currently profitable on an annual basis. The company reported a net loss of $48.1M for FY2023.

is ADXS profitabledoes ADXS make a profitADXS profitabilityADXS profitable company

▸ Source: FMP /income-statement · GAAP · Ayala Pharmaceuticals, Inc. · Ayala Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 15, 2026